Hutch News

Teacher, mom — and living immunotherapy proof of principle

Teacher, mom — and living immunotherapy proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Hutch NewsSeptember 08, 2017
First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy

First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy

Some types of sarcomas elicit a greater immune response than others, which sheds light on how immunotherapy could be used for this connective-tissue cancer, according to a new study in Cancer.
News ReleasesMay 02, 2017
Deploying an ancient defense to kill cancer

Deploying an ancient defense to kill cancer

In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug
Hutch NewsApril 03, 2017